Table 2. Unadjusted Analysis.
No Telehealth Use N = 1684 Mean/Median or N (%) |
|||
---|---|---|---|
Facility: | |||
A | 790 (46.9%) | 44 (63.8%) | <0.01 |
B | 894 (53.1%) | 25 (36.2%) | |
Transfer for admission (yes vs no) | 1360 (18.0%) | 20 (71.0% | 0.05 |
Patient Characteristics: | |||
Age | 71.0 | 73.0 | 0.69 |
Female | 48.3% | 47.8% | 0.93 |
Infectious Source | |||
Urine | 32.7% | 27.5% | 0.37 |
Lung | 38.1% | 49.3% | 0.06 |
Intra-abdominal | 10.2% | 8.7% | 0.84 |
Unknown | 14.1% | 20.3% | 0.15 |
SOFA Score | 3.0 | 3.0 | 0.09 |
Process of Care Outcomes: | |||
Sepsis Bundle | |||
Lactic Acid | 96.5% | 98.6% | 0.73 |
Blood Cultures | 90.1% | 89.9% | 0.84 |
Antibiotics | 79.5% | 78.3% | 0.80 |
IV Fluid* (N=516) | 50.0% | 58.8% | 0.32 |
Repeat Lactic Acid* (N=1192) | 63.8% | 78.0% | 0.04 |
Vasopressors* (N=295) | 55.0% | 63.6% | 0.51 |
Reassessment for Septic Shock* (N=488) | 1.5% | 11.1% | <0.01 |
Primary Outcomes: | |||
Inpatient Mortality | 10.2% | 8.7% | 0.84 |
30-Day Mortality | 19.5% | 18.8% | 0.89 |
Only includes patients for which this bundle component was required